AsclepiX Therapeutics Baltimore-based AsclepiX Therapeutics raises $5M The Johns Hopkins spinout is developing a new treatment for leading causes of blindness. November 15, 2018
Read news items items specific to Ponce Therapeutics or about other Rapha Capital-related entities. Also see scientific articles detailing the rapid advances in the important science of anti-aging
News
angelMD angelMD Investor Group Closes Funding Round with Indago November 13, 2018
Numat Technologies A Material to Save the World? Metal-organic frameworks are compounds that are set to solve some tough challenges: producing water in the desert, removing greenhouse gases from the…
Poseida Therapeutics BCMA in the spotlight as ASH abstracts drop Updated results from promising CAR-T therapies are expected November 2, 2108
Bellicum Pharmaceuticals, Inc. Bellicum Announces Data Presentations on Lead Product Candidate Rivo-cel and Controllable CAR Program at the 60th American Society of Hematology Annual Meeting November 1, 2018
AngelMD AngelMD Portfolio Company Raydiant Oximetry Awarded FDA Breakthrough Device Status The accelerated path to approval through the breakthrough device program will enable better care to millions of mothers and…